Penicillin Allergy
30
4
6
14
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
6.7%
2 terminated out of 30 trials
87.5%
+1.0% vs benchmark
23%
7 trials in Phase 3/4
57%
8 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 14 completed trials
Clinical Trials (30)
Provocation After Nurse-Directed Assessment (PANDA) Study
A Study of the Impact of Penicillin Allergy on Antimicrobial Resistance and ouTcomes
Geisinger Antibiotic Allergy Pilot Program: Assess and Address
Penicillin Allergy Delabeling After a One-Dose Versus Two-Dose Graded Direct Oral Challenge
Risk-stratified Testing for Safe Removal of Penicillin Allergy Labels
The Effect of Providing Stratification of Low Risk Penicillin Allergies on Penicillin Allergy Label Removal
Penicillin De-labeling in the Pediatric Primary Care Setting
Evaluating the Feasibility of High-volume, Low-risk Penicillin Allergy De-labelling to Maximise Efficiency in a Resource-limited Setting
Removal of Erroneous Penicillin Allergy Labels: Implementation Study (REPeAL)
Oral Penicillin Challenge and Allergy De-labeling in Children
Oral Challenge in the Pediatric ED
Penicillin Allergy Delabeling Project
Penicillin Allergy Testing in STD Clinics
Penicillin Allergy Delabeling Among Surgical Patients
Inpatient Penicillin Allergy Delabeling Study
Impact of Pre-operative Penicillin Allergy Evaluation on Surgical Prophylaxis
Safety and Efficacy of an Oral Penicillin Challenge in Low Risk Hospitalized Patients
Effect of Providing Stratification of Low Risk Penicillin Allergies on Penicillin Allergy Label Removal in ICU Setting
Drug Challenges Without Prior Skin Testing
Beta-lactam Pharmacokinetics in Secondary Care